Nicotine inhaler substantially improves smoking cessation treatment Many smokers will tell you that giving up cigarettes is not easy. That said, a recent study published in Nicotine & Tobacco Research ...
Please provide your email address to receive an email when new articles are posted on . There is a current lack of new, approved smoking cessation therapies. The RespiRx Nicotine Inhaler may address ...
There was a notable gap in effectiveness between metered-dose and dry-powder formulations of single-inhaler triple therapy for chronic obstructive pulmonary disease (COPD), according to real-world ...
July 25 (Reuters) - A panel of the European medicines regulator has recommended approving an eco-friendly version of AstraZeneca's (AZN.L), opens new tab inhaler for the treatment of a chronic lung ...
RICHMOND, Va., Jan. 7, 2025 /PRNewswire/ -- Qnovia, Inc., a pharmaceutical company developing inhaled therapeutics across a variety of indication areas leveraging its proprietary inhaled drug delivery ...
Dr. Miguel Divo, a lung specialist at Brigham and Women’s Hospital, sits in an exam room, across from one of his patients with asthma. Joel Rubinstein, a retired psychiatrist, is about to get a ...
- Funds will advance RespiRx ™ Nicotine Inhaler to Marketing Authorization Application (MAA) submission and accelerate the path to commercialization in the UK - RICHMOND, Va., Dec. 10, 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback